Zhejiang Hisoar Pharmaceutical Co., Ltd. announced at its extraordinary general meeting held on 13 November 2019, approved the appointment of Zhu Jianwei and Yao Bing as non-independent directors of the company. The company also approved the appointment of Su Weike, Mao Meiying and Zhang Kejian as independent directors.